Orofacial dyskinesia induced by nasal Ritalin(R) (methylphenidate) sniffing: A rare case report from Switzerland

Marti, G; Fattinger, K; Zimmermann, H; Exadaktylos, A (2012). Orofacial dyskinesia induced by nasal Ritalin(R) (methylphenidate) sniffing: A rare case report from Switzerland. Human & experimental toxicology, 32(3), pp. 332-334. Basingstoke, UK: Sage 10.1177/0960327112467044

Full text not available from this repository.

Ritalin® (methylphenidate) is an amphetamine-like prescription stimulant commonly used in the treatment of attention deficit hyperactivity disorder in children and adults. Recently, the recreational use of Ritalin has increased, particularly among young adults. Well-known symptoms of intoxication include signs of sympathetic nervous stimulation, such as agitation, anxiety, tachycardia, hypertension, headache, tremor, and dizziness. This case report describes oral dyskinesia as a rare presentation of Ritalin intoxication, with the review of pathophysiology and some epidemiological data.

Item Type:	Journal Article (Original Article)
Division/Institute:	04 Faculty of Medicine > Department of Intensive Care, Emergency Medicine and Anaesthesiology (DINA) > University Emergency Center
UniBE Contributor:	Zimmermann, Heinz (B), Exadaktylos, Aristomenis
ISSN:	0960-3271
Publisher:	Sage
Language:	English
Submitter:	Factscience Import
Date Deposited:	04 Oct 2013 14:34
Last Modified:	29 Mar 2023 23:32
Publisher DOI:	10.1177/0960327112467044
PubMed ID:	23174746
Web of Science ID:	000316841000009
URI:	https://boris.unibe.ch/id/eprint/13511 (FactScience: 220063)